Table 6.

Care Coordination Guidelines

Guideline	Level of Evidencea
Consult with cancer treatment team and request a treatment summary and survivorship care plan.	0, III
Coordinate care with other medical specialists to address physical effects (e.g., cardiovascular issues, rheumatologic problems).	0, IA
Refer survivors to behavioral specialist to address psychosocial issues (e.g., cognitive dysfunction, depression, fear of recurrence, body image and sexual dysfunction).	I
Refer survivors to rehabilitative specialists to address issues (e.g., lingering fatigue).	0
Primary care clinician follow-up should: ◦ Check for early local or regional cancer recurrence. ◦ Detect recurrence or 2nd primary cancers early. ◦ Treat ongoing and detect any new physical and psychosocial untoward effects from past colorectal cancer treatment. ◦ Periodically update the survivor’s family history; new colorectal cancers or FAP in the family might make the survivor a candidate for cancer genetic testing.	0, I

FAP indicates familial adenomatous polyposis.

^aLevel of evidence: I, meta analyses of randomized controlled trials (RCTs); IA, RCT of colorectal cancer survivors; IB, RCT based on cancer survivors across multiple sites; IC, RCT not based on cancer survivors, but on general population experiencing a specific long-term or late effect (e.g., chronic diarrhea, sexual dysfunction, etc.); IIA, non-RCT based on colorectal cancer survivors; IIB, non-RCT based on cancer survivors across multiple sites; IIC, non-RCT not based on cancer survivors but on general population experiencing a specific long-term or late effect (e.g., chronic diarrhea, sexual dysfunction, etc.); III, case study; 0, expert opinion, observation, clinical practice, literature review, or pilot study